Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.5glegtPn.js ...

(Reuters) -Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand ...

Paragon 28, Inc. (NYSE:FNA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the company, Ratings reports. Four research analysts have ...

Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a ...

Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...

Fintel reports that on January 30, 2025, Stephens & Co. downgraded their outlook for Paragon 28 (NYSE:FNA) from Overweight to ...

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst ...

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...

Paragon 28 (FNA – Research Report) received a Hold rating and price target from Needham analyst Michael Matson today. The company’s shares ...

Zimmer Biomet Holdings Inc. (ZBH) agreed to acquire all outstanding shares of common stock of Paragon 28 Inc. (FNA) for an upfront ...

Zimmer Biomet is taking steps to expand its foot and ankle orthopedics business with a $1.1 billion deal to acquire ...